StockIQpro
NASDAQ:LFCR

Lifecore Biomedical, Inc. \de\

Track all markets on TradingView
Track all markets on TradingView

Lifecore Biomedical, Inc. \de\'s revenue grew 0.5% in fiscal 2025 to $128.9M while operating margin fell to −13.4%. Free cash flow was −$13.6M, −10.6% of revenue, and the diluted share count fell 5.0%.Summary generated from Lifecore Biomedical, Inc. \de\'s SEC filings. Latest annual report filed Aug 7, 2025.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$128.9M
Revenue growth+0.5%
Revenue, 5-yr CAGR−4.2%
Gross margin31.3%
Operating margin−13.4%
Net margin−30.0%
ROIC−10.9%
Return on equity−612.1%
Debt / equity97.63
Free cash flow−$13.6M
FCF margin−10.6%
Share count change−5.0%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue101111103128129
Operating income−9−12−22−9−17
Net income−32−117−10012−39
Free cash flow−3−49n/a−18−14

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations